This work highlights the potential of P. freudenreichii as a probiotic to improve IBD in a safe and efficient way by restoring the intestinal goblet cell number accompanying with the increase of MUC2 expression as well as exerting anti-inflammatory effects in the distal gut environment. Here, MUC2 is linked to irritable bowel syndrome.